<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0796154" disease_type="Disease or Syndrome" abbrv="SDYS">Simpson-Golabi-Behmel syndrome</z:e> (SGBS) is an <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome caused by deletions in glypican 3 (GPC3) </plain></SENT>
<SENT sid="1" pm="."><plain>SGBS is characterized by pre- and postnatal <z:hpo ids='HP_0001548'>overgrowth</z:hpo>, a characteristic facial appearance, and a spectrum of <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformations</z:e> which overlaps that of other <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes </plain></SENT>
<SENT sid="2" pm="."><plain>We performed GPC3 deletion screening on 80 male patients with somatic <z:hpo ids='HP_0001548'>overgrowth</z:hpo> in the following categories: SGBS (n = 19), possible SGBS (n = 26), including families in which individuals had previously been diagnosed with other <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes, and <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Wiedemann-Beckwith syndrome (WBS)</z:e> (n = 35) </plain></SENT>
<SENT sid="3" pm="."><plain>Using exon-specific PCR and Southern blot analysis, we identified seven GPC3 deletions </plain></SENT>
<SENT sid="4" pm="."><plain>In most cases a clear <z:hpo ids='HP_0001417'>X-linked</z:hpo> family history was not present </plain></SENT>
<SENT sid="5" pm="."><plain>In two cases, GPC3 deletions were identified in patients belonging to pedigrees published previously as other <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes: one with a diagnosis of <z:e sem="disease" ids="C0175695" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Sotos syndrome</z:e> and the other <z:e sem="disease" ids="C0796113" disease_type="Disease or Syndrome" abbrv="">Perlman syndrome</z:e> with <z:hpo ids='HP_0008643'>nephroblastomatosis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>A third patient developed <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo>, a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type not previously described in SGBS </plain></SENT>
<SENT sid="7" pm="."><plain>No GPC3 deletions were identified among the WBS patients </plain></SENT>
<SENT sid="8" pm="."><plain>Direct sequencing of <z:hpo ids='HP_0000001'>all</z:hpo> GPC3 exons in the remaining 13 SGBS patients without GPC3 deletions did not identify any further mutations, raising the possibility of alternative silencing mechanisms and/or other genes in the pathogenesis of SGBS </plain></SENT>
<SENT sid="9" pm="."><plain>Our results validate the clinical specificity of the facial appearance, skeletal/<z:hpo ids='HP_0001155'>hand anomalies</z:hpo>, and <z:hpo ids='HP_0002558'>supernumerary nipples</z:hpo> in patients with GPC3 deletions </plain></SENT>
<SENT sid="10" pm="."><plain>Our data also suggest that <z:hpo ids='HP_0008643'>nephroblastomatosis</z:hpo> and <z:hpo ids='HP_0002884'>hepatoblastoma</z:hpo> are included in the phenotypic spectrum of GPC3 deletions and SGBS, underscoring the importance of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> surveillance in these children </plain></SENT>
</text></document>